Dr Eric Todd Evenson, MD | |
649 Jefferson Ave, Reading, OH 45215-4739 | |
(513) 543-4009 | |
Not Available |
Full Name | Dr Eric Todd Evenson |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Occupational Medicine |
Location | 649 Jefferson Ave, Reading, Ohio |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417464264 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083X0100X | Preventive Medicine - Occupational Medicine | 35-081596 (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Eric Todd Evenson, MD 649 Jefferson Ave, Reading, OH 45215-4739 Ph: (513) 543-4009 | Dr Eric Todd Evenson, MD 649 Jefferson Ave, Reading, OH 45215-4739 Ph: (513) 543-4009 |
News Archive
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St. Michael's Hospital of Unity Health Toronto and Harvard Medical School.
Men aged 55 to 74 years who have low baseline blood levels of prostate specific antigen (PSA) are not likely to benefit from further screening and treatment. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The aim of the study is to help physicians and patients weigh the pros and cons of prostate cancer screening and early detection.
Talking with other people in a friendly way can make it easier to solve common problems, a new University of Michigan study shows. But conversations that are competitive in tone, rather than cooperative, have no cognitive benefits.
African-American women with breast cancer were more likely to have larger, later-stage tumors that were more difficult to treat and also had lower survival rates than Hispanic and Caucasian women who received the same treatment in two independent series of clinical trials examined by researchers from The University of Texas M. D. Anderson Cancer Center.
› Verified 2 days ago